Posted inBiotechnology
Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
Novartis is paying Sironax $125 million to take up its option on a brain delivery platform, gaining control of technology…
Posted inGenetics
Microprotein Atlas Links Brain Immune Cell Dysfunction to Alzheimer’s
Credit: nopparit / iStock / Getty Images Plus Scientists studying Alzheimer’s disease have long focused on genes, proteins, and cells,…
Posted inGenetics
Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles
Neurons [Evgenii Kovalev / E+/ Getty Images] The results of a study by researchers at the University of Colorado Anschutz…
Posted inGenetics
Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies
Emily Gaither Engineer III, Downstream PurificationThermo Fisher Scientific Panelist Emily Gaither Emily Gaither is a bioprocessing engineer specializing in downstream…
Posted inBiotechnology
Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
Sling Therapeutics has closed a $123 million series C round to advance its oral therapy for thyroid eye disease through…
Posted inGenetics
Consolidating Antibody Discovery Data with an AI Platform
Credit: Metamorworks/Getty Images FairJourney Bio (FJBio) selected the Sapio Scientific AI platform, including Sapio’s LIMS, ELN, and AI co-scientist solutions…
Posted inBiotechnology
FDA launches pilot program to speed up sluggish phase 1 trials
After teasing a new initiative to speed up early-stage clinical trials over the summer, the FDA today opened a pilot…
Posted inBiotechnology
Connect’s Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope
Connect Biopharma’s hopes of dethroning Dupixent took a knock as its IL-4/IL-13 blocker missed the primary endpoint of a phase…
Posted inMedical Technology
Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
The Mayo Clinic has partnered with Thermo Fisher Scientific to launch a new group focused on reaping large-scale data that…
Posted inBiotechnology
Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech
Eli Lilly’s ongoing attempt to strengthen its genetic medicine offering has seen the company pledge up to $237 million in…